Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Juni 2018

Planlagt Fastgjort Låst Flyttet Genmab
2.6k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #590

    Evolving Treatment Strategies in Multiple Myeloma: Janssen's Darzalex Leads a Host of Novel Agents in Redefining Treatment Strategies and Approaches - https://www.prnewswire.com/news-releases/evolving-treatment-strategies-in-multiple-myeloma-janssens-darzalex-leads-a-host-of-novel-agents-in-redefining-treatment-strategies-and-approaches-300661357.html

    1 Reply Last reply
    0
    • StockBullS Offline
      StockBullS Offline
      StockBull
      wrote on sidst redigeret af
      #591

      jo ingen tvivl om det er robotter og store fonde, men på et eller andet tidspunkt må der være nogen af de store som finder genmans kurs attraktiv for en lang satsning

      1 Reply Last reply
      0
      • N Offline
        N Offline
        Nickstar
        wrote on sidst redigeret af
        #592

        ja ku man da håbe. jeg er tilgengæld meget tilfreds med køb af Ambu aktier for nogle måneder siden. den rykker! 🙂

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #593

          this Asian thalidomide combo started recruiting last month https://clinicaltrials.gov/ct2/history/NCT03143036?A=1&B=2&C=merged

          1 Reply Last reply
          0
          • P Offline
            P Offline
            Plimsoller
            wrote on sidst redigeret af
            #594

            Kan ikke lige se at den her har været linket.

            1 Reply Last reply
            0
            • P Offline
              P Offline
              Plimsoller
              wrote on sidst redigeret af
              #595

              https://play.borsen.dk/klip/5b1814e945628ff8172250bc

              1 Reply Last reply
              0
              • O Offline
                O Offline
                OHW
                wrote on sidst redigeret af
                #596

                Liger et luk under 970, som nogen nok vil syntes godt om...(shortere)

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #597

                  @Plimsoller could you summarise in 1 sentence you think?

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    Plimsoller
                    wrote on sidst redigeret af
                    #598

                    Firstly they are speaking about a breakthrough in lung cancer treat
                    ment, but that is not Genmab related.

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      Plimsoller
                      wrote on sidst redigeret af
                      #599

                      Second they are speaking about the CAR-T results presented at ASCO. As we know they hopefully/expected 15-18 months progression free, but the result was around 12.

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        Plimsoller
                        wrote on sidst redigeret af
                        #600

                        The expert said that CAR-T is not to be considered to be a competitor to Darzalex. This due to cost and treatment “mode”. 3-4 weeks in the hospital etc.

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #601

                          tak 😉

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #602

                            Subcutaneous daratumumab show benefit in patients with relapsed or refractory multiple myeloma https://www.youtube.com/watch?v=16TrK-zfVms

                            1 Reply Last reply
                            0
                            • P Offline
                              P Offline
                              Plimsoller
                              wrote on sidst redigeret af
                              #603

                              Lastet they touches upon who the focus lies on during these types of conferences - JNJ or Genmab. It is clearly on JNJ, but this year Genmab was for the first time represented physically (a booth or something I imagine), and the interpretation is that they therefore have a lot of faith in their pipeline.

                              1 Reply Last reply
                              0
                              • StockBullS Offline
                                StockBullS Offline
                                StockBull
                                wrote on sidst redigeret af
                                #604

                                Plimsoller. So to get this right. The patients died after 12 month or ?

                                1 Reply Last reply
                                0
                                • P Offline
                                  P Offline
                                  Plimsoller
                                  wrote on sidst redigeret af
                                  #605

                                  Lastet = lastly. Sorry - I am on the phone.

                                  1 Reply Last reply
                                  0
                                  • P Offline
                                    P Offline
                                    Plimsoller
                                    wrote on sidst redigeret af
                                    #606

                                    They said that Bluebird presented results which showet 12 months progression free, where the analysis were hoping for 15-18 months.

                                    1 Reply Last reply
                                    0
                                    • P Offline
                                      P Offline
                                      Plimsoller
                                      wrote on sidst redigeret af
                                      #607

                                      Not sure about the exact definition of progression free. The expert emphadized that CAR-T is not a cure. This was the hope 6 months ago.

                                      1 Reply Last reply
                                      0
                                      • P Offline
                                        P Offline
                                        Plimsoller
                                        wrote on sidst redigeret af
                                        #608

                                        You are welcome

                                        1 Reply Last reply
                                        0
                                        • StockBullS Offline
                                          StockBullS Offline
                                          StockBull
                                          wrote on sidst redigeret af
                                          #609

                                          progression free survival ? PFS

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger